Cardiovascular

Provisio Medical secures FDA 510(k) clearance for SLT IVUS system

Provisio Medical has secured the US Food and Drug Administration’s (FDA) 510(k) clearance of the Provisio Sonic Lumen Tomography (SLT)…

AtaCor Medical secures funding to deliver ICD lead systems

AtaCor Medical has closed a Series C financing round, raising $28m for delivering a next-generation extravascular (EV) implantable cardioverter defibrillator…

Revolutionising cardiac care: Caranx Medical makes history with robotic TAVI breakthrough

Caranx Medical announced a historic milestone in the realm of cardiovascular medicine with the successful completion of the world's inaugural…

Annoviant wins $2.9m NIH grant for paediatric heart conduits

US-based medtech startup Annoviant has received a $2.9m grant from the US National Institutes of Health (NIH) to fund the…

Vivasure implants first venous patient in PerQseal device trial

Vivasure Medical has treated the first venous patient in a clinical trial investigating its PerQseal Elite vascular closure system for…

Simpson secures FDA breakthrough device designation for Acolyte system

The US Food and Drug and Administration (FDA) has granted breakthrough device designation to Simpson Intervention’s Acolyte Image Guided Crossing…

ACC24: V-Wave interatrial shunt misses primary endpoint

US-based medical device company V-Wave released primary data from the RELIEVE-HF pivotal trial of its Ventura interatrial shunt. The randomised…

J&J seeks cardiovascular market growth with $13.1bn Shockwave deal

Johnson & Johnson (J&J) has agreed to acquire US-based cardiovascular device developer Shockwave Medical in one of the biggest medtech…

GE HealthCare adds Caption AI to Vscan Air SL for cardiac imaging

GE HealthCare has announced the integration of Caption AI technology with Vscan Air SL wireless handheld ultrasound system, aimed at…

Kardium’s pulsed field ablation clinical trial enters final stages

Kardium has completed enrolment in a study evaluating its pulsed-field ablation (PFA) device for the treatment of atrial fibrillation. According…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close